Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (621-630 of 645) with videos related to

Pageof 65
Sort By:
European Heart Journal|June 24, 2021
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcomeÒscar Miró, Sònia Jiménez, Alexandre Mebazaa, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Heart Journal|August 31, 2024
Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS scoreFlorian A Wenzl, Peizhi Wang, Mattia Arrigo, et al.
European Journal of Heart Failure|March 10, 2018
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Mark C Petrie, Gerasimos S Filippatos, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|May 20, 2023
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of CardiologyMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
The American Journal of Medicine|October 3, 2020
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across EuropeMateusz Sokolski, Piotr Gajewski, Robert Zymliński, et al.
European Journal of Heart Failure|June 23, 2022
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristicsWilfried Mullens, Jeroen Dauw, Pieter Martens, et al.
Pageof 65

Showing results (621-630 of 645) with videos related to

Sort By:
Pageof 65
European Heart Journal|June 24, 2021
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcomeÒscar Miró, Sònia Jiménez, Alexandre Mebazaa, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Heart Journal|August 31, 2024
Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS scoreFlorian A Wenzl, Peizhi Wang, Mattia Arrigo, et al.
European Journal of Heart Failure|March 10, 2018
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Mark C Petrie, Gerasimos S Filippatos, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|May 20, 2023
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of CardiologyMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
The American Journal of Medicine|October 3, 2020
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across EuropeMateusz Sokolski, Piotr Gajewski, Robert Zymliński, et al.
European Journal of Heart Failure|June 23, 2022
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristicsWilfried Mullens, Jeroen Dauw, Pieter Martens, et al.
Pageof 65